CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Other acquisition Director acquired 2,800 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 1,093 shares (code L)
- 4 Other acquisition Director acquired 2,672 shares (code L)
- 4 Other acquisition Director acquired 3,739 shares (code L)
- 4 Other acquisition Director acquired 747 shares (code L)
- 4 Other acquisition Director acquired 747 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 747 shares (code L)
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Auditor change
- 8-K Event Auditor change
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
Page 11 of 52 · 1,039 filings